Diagnostic and Predictive Utility of Serum Biomarkers and Magnetic Resonance Imaging Predictors for Cognitive Impairment in Patients with Relapsing-Remitting Multiple Sclerosis

血清生物标志物和磁共振成像预测因子对复发缓解型多发性硬化症患者认知障碍的诊断和预测效用

• 批准号: 486263
• 负责人: Sahoo Saswat
• 金额: $ 1.27万
• 依托单位: University of Alberta
• 依托单位国家: 加拿大
• 项目类别: Studentship Programs
• 财政年份: 2022
• 资助国家: 加拿大
• 起止时间: 2022-12-01 至 2023-12-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=486263&lang=en
• 关键词: Biomarkers; Cognitive Impairment; Glial Fibrillary Acidic Protein; Humans; Imaging Biomarkers; Magnetic Resonance Imaging; Multiple Sclerosis; Neurofilament Light Chain; Relapsing-Remitting Multiple Sclerosis; Serum Biomarkers

Cognitive impairment (CI) is a clinical manifestation of Multiple Sclerosis (MS) that has received little attention compared to its other symptoms. There has been a growing interest in being able to detect current and future CI by simply measuring specifi

认知障碍（CI）是多发性硬化症（MS）的临床表现，与其他症状相比几乎没有关注。通过简单地测量指定，能够检测当前和未来的CI越来越兴趣